These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 19931138)

  • 1. The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
    Khalil I; Brewer MA; Neyarapally T; Runowicz CD
    Gynecol Oncol; 2010 Feb; 116(2):282-5. PubMed ID: 19931138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.
    Chien JR; Aletti G; Bell DA; Keeney GL; Shridhar V; Hartmann LC
    J Cell Biochem; 2007 Dec; 102(5):1117-29. PubMed ID: 17879946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for epithelial ovarian cancers.
    Mahata P
    Genome Inform; 2006; 17(2):184-93. PubMed ID: 17503391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelial cancers of the ovary. Recent trends].
    van den Brûle FA; Lambotte R; Castronovo V
    J Gynecol Obstet Biol Reprod (Paris); 1995; 24(3):241-52. PubMed ID: 7622770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery in epithelial ovarian cancer by genomic approaches.
    Mok SC; Elias KM; Wong KK; Ho K; Bonome T; Birrer MJ
    Adv Cancer Res; 2007; 96():1-22. PubMed ID: 17161674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and prognostic significance in ovarian cancer.
    Tammela J; Odunsi K
    Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia.
    Stewart SL; Querec TD; Ochman AR; Gruver BN; Bao R; Babb JS; Wong TS; Koutroukides T; Pinnola AD; Klein-Szanto A; Hamilton TC; Patriotis C
    Cancer Res; 2004 Nov; 64(22):8177-83. PubMed ID: 15548682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer.
    Sawiris GP; Sherman-Baust CA; Becker KG; Cheadle C; Teichberg D; Morin PJ
    Cancer Res; 2002 May; 62(10):2923-8. PubMed ID: 12019173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological dynamics of human ovarian surface epithelial cells in epithelial ovarian carcinogenesis.
    Okamura H; Katabuchi H
    Int Rev Cytol; 2005; 242():1-54. PubMed ID: 15598466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
    Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse molecular pathways in ovarian cancer and their clinical significance.
    Ricciardelli C; Oehler MK
    Maturitas; 2009 Mar; 62(3):270-5. PubMed ID: 19193504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinately up-regulated genes in ovarian cancer.
    Hough CD; Cho KR; Zonderman AB; Schwartz DR; Morin PJ
    Cancer Res; 2001 May; 61(10):3869-76. PubMed ID: 11358798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
    Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
    Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.